[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 42,431
Sort by:

2013 Italian Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 4,720.00

... new 970-page report from Venture Planning Group comprehensive analysis of the Italian microbiology testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views ...

January 2013 970 pages

2013 Japanese Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 6,240.00

... -page report from Venture Planning Group presents a comprehensive analysis of the Japanese microbiology testing market, including: Major issues pertaining to the ... , and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed ...

January 2013 976 pages

2013 Spanish Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 4,720.00

... -page report from Venture Planning Group presents a comprehensive analysis of the Spanish microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

January 2013 960 pages

2013 UK Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 4,720.00

... 978-page report from Venture Planning Group presents a comprehensive analysis of the UK microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

January 2013 978 pages

2013 US Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 7,520.00

... 1,037-page report from Venture Planning Group presents a comprehensive analysis of the US microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

January 2013 1037 pages

US Telelaparoscopy Opportunity Analysis

US$ 1,000.00

... Our extensive research and analysis have led us to identify three areas, where unlimited opportunities lie. Amongst these, “US Telelaparoscopy Opportunity Analysis”, provides insights on the Telelaparoscopy general surgery. Presented in 25 slides, this report unfolds the tremendous scope of Telelaparoscopy - ...

December 2012 25 pages

Disease Management and Health Monitoring for ACOs 1Q 2013

US$ 3,500.00

... ) and Accountable Care Organization (ACO). It analyzes how care management services and home health monitoring technologies will be deployed in these new care services ... ACO structure and operational models will influence adoption of care management service and health monitoring technologies.”

December 2012 68 pages

2013 Leading Flow Cytometry Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,480.00

... report from Venture Planning Group presents strategic analyses of major current and emerging suppliers of flow cytometry analyzers and consumables in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. ...

December 2012 25 pages

2013 French Hospital Cancer Diagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital cancer diagnostics market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, ...

December 2012 533 pages

2013 German Hospital Cancer Diagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 533 pages, 40 tables, and presents a comprehensive analysis of the German hospital cancer diagnostics market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, ...

December 2012 533 pages

2013 Italian Hospital Cancer Diagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital cancer diagnostics market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key ...

December 2012 525 pages

2013 Japanese Hospital Cancer Diagnostics Market

US$ 3,880.00

This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key ...

December 2012 537 pages

2013 Spanish Hospital Cancer Diagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital cancer diagnostics market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key ...

December 2012 521 pages

2013 UK Hospital Cancer Diagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital cancer diagnostics market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

December 2012 527 pages

2013 US Hospital Cancer Diagnostics Market

US$ 5,200.00

This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...

December 2012 567 pages

2013 Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies for Suppliers

US$ 23,520.00

... new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. The Clinical Chemistry and Immunodiagnostics Markets is a unique worldwide market intelligence and technology assessment study designed to help current suppliers and potential ...

December 2012 1115 pages

2013 France Clinical Chemistry and Immunodiagnostics Markets

US$ 4,320.00

... and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

December 2012 542 pages

2013 Germany Clinical Chemistry and Immunodiagnostics Markets

US$ 4,320.00

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

December 2012 578 pages

2013 Italy Clinical Chemistry and Immunodiagnostics Markets

US$ 4,320.00

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

December 2012 561 pages

2013 Japan Clinical Chemistry and Immunodiagnostics Markets

US$ 5,440.00

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

December 2012 559 pages

2013 Spain Clinical Chemistry and Immunodiagnostics Markets

US$ 4,320.00

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

December 2012 568 pages

2013 UK Clinical Chemistry and Immunodiagnostics Markets

US$ 4,320.00

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

December 2012 563 pages

2013 US Clinical Chemistry and Immunodiagnostics Markets

US$ 8,560.00

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

December 2012 600 pages

2013 France Flow Cytometry Market: Opportunities and Strategies for Suppliers

US$ 2,880.00

... -page report from Venture Planning Group presents a comprehensive analysis of the French flow cytometry market, including: Major issues pertaining to the French ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 146 pages

2013 Germany Flow Cytometry Market: Opportunities and Strategies for Suppliers

US$ 2,880.00

... -page report from Venture Planning Group presents a comprehensive analysis of the German flow cytometry market, including: Major issues pertaining to the German ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 147 pages

2013 Italy Flow Cytometry Market: Opportunities and Strategies for Suppliers

US$ 2,880.00

... -page report from Venture Planning Group presents a comprehensive analysis of the Italian flow cytometry market, including: Major issues pertaining to the Italian ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 142 pages

2013 Japan Flow Cytometry Market: Opportunities and Strategies for Suppliers

US$ 3,600.00

... page report from Venture Planning Group presents a comprehensive analysis of the Japanese flow cytometry market, including: Major issues pertaining to the Japanese ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 142 pages

2013 Spain Flow Cytometry Market: Opportunities and Strategies for Suppliers

US$ 2,880.00

... -page report from Venture Planning Group presents a comprehensive analysis of the Spanish flow cytometry market, including: Major issues pertaining to the Spanish ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 140 pages

2013 UK Flow Cytometry Market: Opportunities and Strategies for Suppliers

US$ 2,880.00

... new 146-page report from Venture Planning Group presents a comprehensive analysis of the UK flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 146 pages

2013 US Flow Cytometry Market: Opportunities and Strategies for Suppliers

US$ 4,720.00

... new 174-page report from Venture Planning Group presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

December 2012 174 pages

2013 Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

US$ 22,880.00

... ; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than ... volume and sales forecasts for over 40 transfusion diagnostic tests, including NAT, by country and market segment: Blood Centers Plasma Fractionation ...

December 2012 800 pages

2013 France Transfusion Diagnostic Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 430-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... . Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in French ...

December 2012 430 pages

2013 Germany Transfusion Diagnostic Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 426-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... . Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in German ...

December 2012 426 pages

2013 Italy Transfusion Diagnostic Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 412-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... . Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Italian ...

December 2012 412 pages

2013 Japan Transfusion Diagnostic Testing Market: Opportunities and Strategies for Suppliers

US$ 5,440.00

Highlights This new 426-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Japanese ...

December 2012 426 pages

2013 Spain Transfusion Diagnostic Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 425-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... . Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Spanish ...

December 2012 425 pages

2013 UK Transfusion Diagnostic Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 422-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in ...

December 2012 422 pages

2013 US Transfusion Diagnostic Testing Market; Opportunities and Strategies for Suppliers

US$ 7,120.00

Highlights This new 460-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major ... forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in US community and regional blood centers, ...

December 2012 460 pages

2013 France Tumor Marker Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 585-page analysis of the French tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...

December 2012 585 pages

2013 Italy Tumor Marker Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 570-page analysis of the Italian tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...

December 2012 570 pages

2013 Germany Tumor Marker Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 585-page analysis of the German tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...

December 2012 585 pages

2013 Japan Tumor Marker Testing Market: Opportunities and Strategies for Suppliers

US$ 5,360.00

Highlights This new 590-page analysis of the Japanese tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...

December 2012 590 pages

2013 Spain Tumor Marker Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 565-page analysis of the Spanish tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...

December 2012 595 pages

2013 UK Tumor Marker Testing Market: Opportunities and Strategies for Suppliers

US$ 4,320.00

Highlights This new 575-page analysis of the UK tumor marker testing market report from Venture Planning Group including: Major issues ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...

December 2012 575 pages

2013 US Tumor Marker Testing Market: Opportunities and Strategies for Suppliers

US$ 6,960.00

Highlights This new 620-page analysis of the US tumor marker testing market report from Venture Planning Group including: Major issues ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...

December 2012 620 pages

2013 European Coagulation Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies

US$ 14,800.00

... testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, continuing contraction ...

December 2012 500 pages

2013 CEA Testing Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country

US$ 3,080.00

... report from Venture Planning Group presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ... disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...

December 2012 250 pages

2013 Occult Blood Testing Market: US, Europe, Japan Test Volume and Sales Forecasts by Country

US$ 3,080.00

... from Venture Planning Group presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...

December 2012 243 pages

2013 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country

US$ 3,080.00

... , including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well ... disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...

December 2012 242 pages

2013 Pap Smear/HPV Testing Market: US, Europe, Japan Test Volume and Sales Forecasts by Country

US$ 3,080.00

... from Venture Planning Group presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...

December 2012 243 pages

Filters

Search

Categories

675
84
1,065
32,726
152
69
819
657
1,863
4,251
70

Publishers

8
9
35
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
46
11
77
1
14
2
22
3
74
40,332
1
40
2
17
15
24
85
6
10
50
11
62
48
1
45
23
49

Regions

280
15
1
134
138
137
137
136
136
135
134
131
130
175
38
15,523
447
192
191
191
137
4
3
2
198
197
196
196
196
195
194
194
194
192
106
193
195
193
192
107
195
138
203
194
189
200
198
196
139
105
195
194
194
193
195
176
198
197
138
112
197
197
195
195
193
193
138
138
136
135
135
1
1
200
198
197
195
194
198
197
196
195
195
195
194
194
194
195
195
191
138
138
137
108
16
1
1
198
1
108
1,215
1,213
1,197
1,192
1,172
245
2
263
194
195
203
197
1,227
1,153
1,668

Price

Date

Pages

Offers

33
6
1
15
84